Product image of Нимотоп S (Nimodipine) supplied by GNH India

Нимотоп S

Active Ingredient:
Nimodipine
Origin:
EU

Нимотоп S (Nimodipine)

Nimotop S is an intravenous calcium channel blocker used to prevent vasospasm after subarachnoid hemorrhage. It helps maintain cerebral blood flow during critical care. Nimotop S injection is administered under medical supervision for targeted vascular support. This EU-sourced solution is designed for hospital and clinical environments.

Manufacturer / TM Owner

Laboratoire Xo

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Nimotop S is primarily used to prevent or reduce cerebral vasospasm following a subarachnoid hemorrhage, a type of brain bleed. It works by relaxing blood vessels in the brain to improve circulation. The medication is intended for patients in acute care settings where close monitoring is available. It supports recovery by reducing the risk of secondary complications linked to reduced blood flow.

Side Effects

  • Nimotop S helps maintain steady blood flow to the brain by relaxing arterial muscles. Patients may experience improved oxygen delivery to brain tissues during treatment. The medication is designed to act selectively on cerebral blood vessels, minimizing widespread effects. Its effects are typically observed within hours of administration.

Precautions & Warnings

  • Nimotop S should only be handled and administered by healthcare professionals in controlled settings. Patients with severe hypotension or unstable blood pressure require careful monitoring during infusion. The solution must be used as directed and stored according to manufacturer guidelines. Always check compatibility with other intravenous medications before administration.

Avoid Interactions

  • Nimotop S may interact with other drugs that affect blood pressure, such as antihypertensives or vasodilators. Caution is advised when combining with CYP3A4 inhibitors, which can increase nimodipine levels. Alcohol and grapefruit products may also influence its effects. Always inform healthcare providers of all medications being used.

Frequently Asked Questions

Nimotop S is used to prevent vasospasm in the brain after a subarachnoid hemorrhage.

It is given as an intravenous infusion under medical supervision in a clinical setting.

No, it requires administration by healthcare professionals in a hospital or care facility.

Inform your doctor about all medications, supplements, and conditions, especially low blood pressure.

Common effects may include changes in blood pressure or heart rate during infusion.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nimodipine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT